Antisense Therapeutics (ASX:ANP)

Mark Diamond
CEO
Market Cap (AUD): 37.15M
Sector: Health Care
Last Trade (AUD): 0.073 +-0 (+-3.95%)
Tab Bar

1. About

Antisense Therapeutics Limited (ASX:ANP) is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk